Ian Weidling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ian Weidling has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Heather M. Wilkins
University of Kansas
2 shared publications - Lesya Novikova
University of Kansas Alzheimer’s Disease Research Center, Kansas City, KS, USA
2 shared publications - Russell H. Swerdlow
Alzheimer’s Disease Research Center, University of Kansas Medical Center, Kansas City, USA
2 shared publications Xiaowan Wang
University of Kansas Alzheimer’s Disease Research Center, Kansas City, KS, USA
2 shared publicationsAlexander P. Gabrielli
University of Kansas Alzheimer's Disease Research Center, University of Kansas, Fairway, KS, USA
1 shared publicationAmol Ranjan
University of Kansas Alzheimer's Disease Research Center, University of Kansas, Fairway, KS, USA
1 shared publication
Latest Publications
- 29 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Chronic mitochondrial DNA depletion alters MAPT splicing and increases tau levels
Background: In Alzheimer's disease (AD), tau protein aggregates to form neurofibrillary tangles (NFTs). The cellular changes favoring AD brain NFT formation remain incompletely understood. AD brains also display mitochondrial defects, including reduced mitochondrial DNA (mtDNA) copy number. Objective: We considered whether mtDNA depletion alters tau homeostasis. Methods: We assessed tau mRNA using short-read mRNA sequencing and PCR, and tau protein using immunochemistry, in SH-SY5Y cells with chronic mtDNA depletion (ρ0). Results: mtDNA depletion increased tau expression and resulted in alternatively spliced isoforms, elevated 4R and exon 4a-containing MAPT transcripts, and consistently detectable big tau protein. ρ0 cells also displayed an elevated MAPT exon 13 3’Untranslated Region (UTR): Coding DNA sequence (CDS) ratio. Phosphorylation at amino acid positions 217 and 181 decreased. Conclusions: Mitochondrial dysfunction affects tau expression, splicing, and 3’UTR retention while increasing tau protein levels and modifying its phosphorylation. These studies hold AD relevance as they provide evidence for a relationship between two AD-associated phenomena, defective mitochondrial function and altered MAPT regulation.
- 29 September 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Chronic mitochondrial DNA depletion alters MAPT splicing and increases tau levels
Background: In Alzheimer's disease (AD), tau protein aggregates to form neurofibrillary tangles (NFTs). The cellular changes favoring AD brain NFT formation remain incompletely understood. AD brains also display mitochondrial defects, including reduced mitochondrial DNA (mtDNA) copy number. Objective: We considered whether mtDNA depletion alters tau homeostasis. Methods: We assessed tau mRNA using short-read mRNA sequencing and PCR, and tau protein using immunochemistry, in SH-SY5Y cells with chronic mtDNA depletion (ρ0). Results: mtDNA depletion increased tau expression and resulted in alternatively spliced isoforms, elevated 4R and exon 4a-containing MAPT transcripts, and consistently detectable big tau protein. ρ0 cells also displayed an elevated MAPT exon 13 3’Untranslated Region (UTR): Coding DNA sequence (CDS) ratio. Phosphorylation at amino acid positions 217 and 181 decreased. Conclusions: Mitochondrial dysfunction affects tau expression, splicing, and 3’UTR retention while increasing tau protein levels and modifying its phosphorylation. These studies hold AD relevance as they provide evidence for a relationship between two AD-associated phenomena, defective mitochondrial function and altered MAPT regulation.
- 21 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (2) , 714-727
An aging hallmark, Alzheimer's disease, and APOE nexus
Background: The commonality of Alzheimer's disease (AD) in the elderly suggests connections between aging and AD biology. APOE biology is also tied to AD. Objective: We sought to link three aging hallmarks (loss of proteostasis, mitochondrial dysfunction, deregulated nutrient sensing) to APOE biology. Methods: We altered SH-SY5Y cell proteostasis directly via heat shock, integrated stress response inhibition (ISRIB), or autophagy inhibition (chloroquine), and indirectly by perturbing mitochondria (mtDNA depletion; oligomycin). We also exposed induced pluripotent stem cell-derived neurons to ISRIB and chloroquine. Conversely, we mitigated protein stress with rapamycin. We assessed intervention impact on APOE expression. Results: Increasing protein stress elevated and decreasing protein stress lowered APOE expression. In SH-SY5Y cells rapamycin blocked oligomycin-induced mTOR 2448 phosphorylation, Akt 473 phosphorylation, and APOE expression. In chloroquine-treated neurons rapamycin reduced mTOR phosphorylation and APOE expression. Discussion: Protein stress initiates APOE expression and facilitates mitochondrial dysfunction's impact on APOE by engaging the mTOR pathway. Our findings link aging and AD biology.
- 21 May 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 112 (2) , 714-727
An aging hallmark, Alzheimer's disease, and APOE nexus
Background: The commonality of Alzheimer's disease (AD) in the elderly suggests connections between aging and AD biology. APOE biology is also tied to AD. Objective: We sought to link three aging hallmarks (loss of proteostasis, mitochondrial dysfunction, deregulated nutrient sensing) to APOE biology. Methods: We altered SH-SY5Y cell proteostasis directly via heat shock, integrated stress response inhibition (ISRIB), or autophagy inhibition (chloroquine), and indirectly by perturbing mitochondria (mtDNA depletion; oligomycin). We also exposed induced pluripotent stem cell-derived neurons to ISRIB and chloroquine. Conversely, we mitigated protein stress with rapamycin. We assessed intervention impact on APOE expression. Results: Increasing protein stress elevated and decreasing protein stress lowered APOE expression. In SH-SY5Y cells rapamycin blocked oligomycin-induced mTOR 2448 phosphorylation, Akt 473 phosphorylation, and APOE expression. In chloroquine-treated neurons rapamycin reduced mTOR phosphorylation and APOE expression. Discussion: Protein stress initiates APOE expression and facilitates mitochondrial dysfunction's impact on APOE by engaging the mTOR pathway. Our findings link aging and AD biology.